Big trials push beyond obesity to see if GLP-1s can quell alcohol, drug cravings
Coverage of new trials from Lilly and testing whether GLP-1 medications can reduce cravings for alcohol and drugs.
Oct 20, 2026
GLP-1s and criminality: US trial will test whether semaglutide can fight crime
Luke Taylor reports on CASPR and Allegheny County’s planned $13.3 million semaglutide trial, quoting Nicholas Reville on research into criminal-justice involvement and other social outcomes.
Oct 17, 2026
Allegheny County to test Ozempic, similar drugs on opioid and alcohol addiction treatment
Megan Trotter reports on CASPR and Allegheny County’s planned $13.3 million semaglutide trial, which will study addiction treatment alongside employment, housing, and criminal-justice outcomes.
Forget cookies — new research reveals GLP-1s might relieve cocaine cravings too
Naomi Schaefer Riley discusses CASPR and Allegheny County’s planned GLP-1 addiction trial and quotes Nicholas Reville on research into reducing cravings.
Oct 15, 2026
Can GLP-1s trim more than weight? Effect on drug use, crime to be studied in Pittsburgh.
Oliver Morrison reports on CASPR’s planned 1,200-person GLP-1 trial in Allegheny County, examining alcohol and opioid use alongside employment, housing, and criminal-justice outcomes.
New study examines GLP-1 impact on interactions with criminal justice system, employment, housing stability
Theresa Gaffney covers CASPR and Allegheny County's planned trial of semaglutide in up to 1,200 people with alcohol or opioid use disorder, tracking recovery, recidivism, employment, and housing outcomes.
Oct 7, 2026
The evidence suggesting GLP-1s can curb drug and alcohol cravings
William Brangham reports on both of CASPR's GLP-1 pilot programs, at Caron Treatment Centers in Pennsylvania and OpenDoors in Rhode Island, as part of the NewsHour series GLP-1s: Reshaping America.
Woman Says GLP-1 Helped Her Stop Drinking After Alcohol Addiction
PEOPLE profiles Jessica Vega and her experience with GLP-1 treatment through OpenDoors’ She Thrives pilot program.
“Everything changed”: Woman says grant-funded GLP-1 program helped cure her alcohol addiction
Jessica Vega and Nick Horton discuss OpenDoors’ GLP-1 pilot and Vega’s recovery. WPRI reporting, republished by AOL.
There’s Help Outside
Brown Alumni Magazine covers the OpenDoors pilot, quotes CASPR’s Nicholas Reville, and highlights CASPR’s $50,000 seed funding and Dr. Steven Klein’s role.
Could GLP-1s Cure Addiction — and Crime?
Arnold Ventures' Fighting Crime podcast features Nicholas Reville and CASPR advisor Keith Humphreys, and visits CASPR and OpenDoors' GLP-1 pilot program to explore the potential of new addiction treatments to reduce crime.
Jun 15, 2026
Are GLP-1s Miracle Drugs for Addiction, Too?
Rhode Island Monthly profiles participants in the OpenDoors pilot, quotes Nicholas Reville and Dr. Steven Klein, and credits CASPR’s funding.
Can GLP-1s quiet drug cravings? How a R.I. program is finding out
The Providence Journal profiles participants in CASPR and OpenDoors' GLP-1 pilot program for women recently released from prison or experiencing homelessness, who report curbed cravings for illicit drugs and alcohol.
How GLP-1s helped a Rhode Island mom get sober after battling alcoholism
NPR's Here & Now profiles a participant in CASPR's OpenDoors pilot program whose alcohol addiction was transformed by GLP-1 treatment.
'I feel reborn': How GLP-1 drugs are transforming the lives of people struggling with addiction
The Globe reports on CASPR's OpenDoors program in Providence and the life-changing impact of GLP-1 medications on people in recovery.
Nov 16, 2025
GLP-1 weight-loss treatment is being used for alcohol and drug addiction
The Post covers both of CASPR's GLP-1 pilot programs — at Caron Treatment Centers in Pennsylvania and OpenDoors in Rhode Island — the only two programs of their kind in the world.
The Drug That Took Away More Than Her Appetite
Maia Szalavitz reports on CASPR's SheThrives program — offering GLP-1 medications to women with substance use disorder histories in post-incarceration housing in Rhode Island.
GLP-1 drugs for addiction: Confidence grows in new treatment option
STAT reports on CASPR's partnership with Caron Treatment Centers and Dr. Steven Klein's work integrating GLP-1 medications into residential addiction treatment.
Weight Loss Drugs for Curing Addiction? With Nicholas Reville
CASPR executive director Nicholas Reville joins Chris Hayes on WITHpod to discuss how GLP-1 medications may represent the biggest breakthrough in addiction medicine in 50 years.
Jun 22, 2026
We should restrict gambling marketing to protect youth
In an op-ed, Michigan State Sen. Erika Geiss argues that gambling ads have flooded TV, radio, billboards and phone screens, and calls for limits on how online gaming and sports betting are marketed to young people.
In Florida, it's easier than ever to gamble your life savings from the couch
The Miami Herald investigates Florida's permissive online sports betting regime — citing CASPR's report card giving the state an F (49/100) and quoting Nicholas Reville on app design, prevention-stage policy, and bet/loss limits.
CASPR's Nicholas Reville: Public Policy Misses the Mark on Problem Gambling
In a Q&A, CASPR co-founder Nicholas Reville discusses the industry's fixation on post-addiction policies, state legislatures being misled by operators, and compelling anecdotal evidence that GLP-1s can treat gambling disorders.
Mar 7, 2026
New report: Oregon sports betting fails to fully protect residents
A national report gave Oregon an F grade for protecting residents from online gambling addiction, citing the state's monopoly partnership with DraftKings and lack of cross-platform self-exclusion. An estimated 88,000 Oregon residents have gambling disorders.
Sports betting protections in Missouri and Kansas get failing grades
The Beacon covers CASPR's report giving Missouri and Kansas failing grades for inadequate online gambling protections, highlighting a lack of loss limits and addiction prevention measures.
Mar 5, 2026
Massachusetts earns a D in new online gambling rankings
Boston.com reports on CASPR's online gambling report card, which gives Massachusetts a D and highlights weak addiction safeguards across New England.
Mar 4, 2026
Arizona gets D grade in an online gambling safety report card
CASPR's state-by-state online gambling safety scorecard ranks Arizona among states with weak consumer protections.
Mar 4, 2026
Ohio's online gambling and consumer protections aren't paying off, study finds
CASPR's gambling scorecard finds Ohio's consumer protections fall short despite being one of the largest sports betting markets in the country.